Enhancing Patient Safety with Advanced Radiation Dosimetry
Radiation therapy remains a cornerstone in cancer treatment, employing high-energy radiation to target and eradicate tumors. Precision in this treatment is crucial, as even minor inaccuracies in radiation delivery can impact therapeutic outcomes or increase the risk of adverse side effects. Radiation dosimetry plays a critical role in ensuring the delivery of accurate radiation doses in medical procedures, including radiotherapy, diagnostic imaging, and nuclear medicine.
The International Atomic Energy Agency (IAEA) has been proactive in bolstering dosimetry practices globally. Through its Dosimetry Laboratory in Seibersdorf, Austria, which has served the global community since 1961, the IAEA provides essential calibration, audit services, and training. With recent renovations, the facility now boasts the Curie-Meitner Nuclear Applications Centre, which enhances support for safe and effective use of nuclear technologies.
Zakithi Msimang, an IAEA medical radiation physicist, underscores the dual services offered by the Dosimetry Laboratory: calibration and audits. These services are pivotal in enabling hospitals to administer the radiation dose prescribed accurately, thereby improving treatment precision and patient safety.
Historically, the IAEA has refined its dosimetry services to enhance accuracy and cost-effectiveness. Beginning with early comparisons using Fricke dosimeters and thermoluminescence dosimeters (TLDs), the Laboratory transitioned to radiophotoluminescent dosimetry (RPLD) systems in 2017. Calibration services have also evolved from air-based measurements to include absorbed dose to water using cobalt-60 photon beams and high-dose-rate brachytherapy calibrations.
To address disparities in dosimetry capabilities globally, the IAEA collaborates with the International Centre for Theoretical Physics, offering postgraduate training largely targeting professionals from low- and middle-income countries. These initiatives, coupled with hosting workshops and issuing guidance, fortify the skills required for precise dosimetry application.
Continuous improvement and innovation are integral to the Laboratory's operations. By fostering collaborations through coordinated research projects (CRPs) and the IAEA/WHO Secondary Standards Dosimetry Laboratory (SSDL) Network, the IAEA encourages advancements in brachytherapy and diagnostic radiology dosimetry.
The future of global dosimetry hinges on swiftly bridging the gap between technological advances in medical radiation and the establishment of globally recognized measurement protocols. The International Symposium on Standards, Applications, and Quality Assurance in Medical Radiation Dosimetry (IDOS 2026) will serve as a platform to discuss these emerging trends and innovate further in the field.
By spearheading international efforts in dosimetry enhancement, the IAEA continues to play a fundamental role in improving cancer treatment outcomes, ensuring both safety and efficacy for patients worldwide.